Summary
Endogenous infections with multi-resistantS. epidermidis are among the leading causes of nosocomial infections. The effect of hospitalization and antimicrobial therapy on antimicrobial resistance of colonizing staphylococci was determined from swabs of the nose, hand, axilla and groin from 157 patients on one day. Hospitalization for > 72 hours, compared with < 72 hours, was associated with a higher percentage of isolates resistant to oxacillin (56% versus 19%), gentamicin (40% versus 15%), trimethoprim (36% versus 17%), clindamycin (56% versus 17%), and fusidic acid (20% versus 4%; p<0.01 for all), but not to rifampicin (6% versus 1%) or fosfomycin (43% versus 34%, p>0.05 for both). Concurrent antimicrobial therapy resulted in increased resistance to oxacillin (61% versus 28%), gentamicin (43% versus 20%), and clindamycin (60% versus 26%; p<0.01 for all), but not to trimethoprim (39% versus 23%), fusidic acid (19% versus 9%), rifampicin (6% versus 3%), or fosfomycin (46% versus 38%, p>0.05 for all). The increase in resistant isolates was not independent, since hospitalization and antimicrobial therapy were correlated (p<0.001). After adjustment for potential risk factors such as diabetes mellitus, central venous catheters, and hemodialysis, the odds ratio for oxacillin resistance was 2.8–3.6. None of the risk factors showed statistically significant results, except for the presence of neoplastic disease, which had a significant interaction (P=0.035). The within-subgroup odds ratios for patients with and without neoplasm were 4.2 (95% CI, 2.3–5.7) and 2.1 (95% CI, 0.78–3.12), respectively. These results show that hospitalization for more than three days, with or without antimicrobial therapy, and the presence of neoplastic disease are associated with increased antimicrobial resistance in colonizingS. epidermidis.
Article PDF
Similar content being viewed by others
References
Gaynes R, Richards C, Edwards J, et al (2001) Feeding back surveillance data to prevent hospital-acquired infections. Emerg Infect Dis 7: 295–298
Wenzel RP (1986) Methicillin-resistant S. aureus and S. epidermidis strains: modern hospital pathogens. Infect Control 7: 118–119
Wenzel RP, Edmond MB (2000) Managing antibiotic resistance. N Engl J Med 343: 1961–1963
Gastmeier P, Geffers C, Sohr D, Schwab F, Behnke M, Ruden H (2003) Surveillance of nosocomial infections in intensive care units. Current data and interpretations. Wien Klin Wochenschr 115: 99–103
von Eiff C, Proctor RA, Peters G (2001) Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med 110: 63–64, 69–70, 73–76
von Eiff C, Becker K, Metze D, et al (2001) Intracellular persistence of Staphylococcus aureus small-colony variants within keratinocytes: a cause for antibiotic treatment failure in a patient with darier’s disease. Clin Infect Dis 32: 1643–1647
von Eiff C, Becker K, Machka K, Stammer H, Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344: 11–16
Wenzel RP (1995) The Lowbury Lecture. The economics of nosocomial infections. J Hosp Infect 31: 79–87
Wenzel RP, Perl TM (1995) The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 31: 13–24
Vincent J (2002) Nosocomial infection and outcome. Nutrition 18: 713–714
Vincent J (1993) Staphylococcal bacteremia. Indian Pediatr 30: 1051
Vincent JL (2000) Microbial resistance: lessons from the EPIC study, European Prevalence of Infection. Intensive Care Med 26 [Suppl 1]: S3–8
Weinbren M, Struthers K (2002) Emergence of Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin during therapy. J Antimicrob Chemother 50: 306–307
Geisel R, Schmitz FJ, Fluit AC, Labischinski H (2001) Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 20: 685–697
Hiramatsu K (1998) The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan. Am J Med 104: 7S-10S
Smith TL, Pearson ML, Wilcox KR, et al (1999) Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 340: 493–501
Allerberger F, Fida P, Grossgut R, Schonbauer M, Wurzner H (2003) Antibiotics in horticulture and antibiotic feed additives in animal husbandry, Austria 2002. Wien Klin Wochenschr 115: 615–617
Berger A, Rohrmeister K, Haiden N, Assadian O, Kretzer V, Kohlhauser C (2002) Serratia marcescens in the neonatal intensive care unit: re-emphasis of the potentially devastating sequelae. Wien Klin Wochenschr 114: 1017–1022
Bago J, Halle ZB, Strinic D, et al (2002) The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication — a randomised controlled trial. Wien Klin Wochenschr 114: 448–453
Berntsen CA, McDermott W (1960) Increased transmissibility of staphylococci to patients receiving an antimicrobial drug. N Engl J Med 262: 637–642
Verhoef J, Gupta R (1999) Surveillance of resistance against antimicrobial agents: a European perspective. J Hosp Infect 43 [Suppl]: S93–96
Hoiby N, Jarlov JO, Kemp M, et al (1997) Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis. Lancet 349: 167–169
Monitoring hospital-acquired infections to promote patient safety — United States, 1990–1999 (2000), MMWR Morb Mortal Wkly Rep 49: 149–153
National Nosocomial Infections Surveillance (NNIS) System Report (2001) Data summary from January 1992–June 2001, issued August 2001. Am J Infect Control 29: 404–421
National Nosocomial Infections Surveillance (NNIS) System Report (2002) Data summary from January 1992 to June 2002, issued August 2002, Am J Infect Control 30; 458–475
National Nosocomial Infections Surveillance (NNIS) System Report (2003) Data summary from January 1992 through June 2003, issued August 2003, Am J Infect Control 31: 481–498.
Bauer AW, Kirby WM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol 36: 49–52
Jones RN, Cullen S (2002) Re-evaluations of disk diffusion quality control ranges for 11 drugs: report from the QC working group of the national committee for clinical laboratory standards. Int J Antimicrob Agents 20: 289–292
Fidalgo S, Vazquez F, Mendoza MC, Perez F, Mendez FJ (1990) Bacteremia due to Staphylococcus epidermidis: microbiologic, epidemiologic, clinical, and prognostic features. Rev Infect Dis 12: 520–528
Souvenir D, Anderson DE Jr, Palpant S, et al (1998) Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients, J Clin Microbiol 36: 1923–1926
Stefani S, Varaldo PE (2003) Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 9: 1179–1186
Nicoletti G, Bonfiglio G, Bartoloni A, et al (2000) Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison. Int J Antimicrob Agents 15: 265–269
Kloos WE, Bannerman TL (1994) Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 7: 117–140
Weinbaum FI, Lavie S, Danek M, Sixsmith D, Heinrich GF, Mills SS (1997) Doing it right the first time: quality improvement and the contaminant blood culture. J Clin Microbiol 35: 563–565
Larson E (2001) Hygiene of the skin: when is clean too clean? Emerg Infect Dis 7: 225–230
Pittet D (2000) Improving compliance with hand hy giene in hospitals. Infect Control Hosp Epidemiol 21: 381–386
Pittet D (2001) Compliance with hand disinfection and its impact on hospital-acquired infections. J Hosp Infect 48 [Suppl A]: S40–46
Pittet D (2001) Improving adherence to hand hygiene practice: a multidisciplinary approach. Emerg Infect Dis 7: 234–240
Pittet D (2002) Promotion of hand hygiene: magic, hype, or sicentific challenge? Infect Control Hosp Epidemiol 23: 118–119
Pittet D (2003) Hand hygiene: improved standards and practice for hospital care. Curr Opin Infect Dis 16: 327–335
Pittet D, Bonten MJ (2000) Towards invasive diagnostic techniques as standard management of ventilator-associated pneumonia. Lancet 356: 874
Pittet D, Boyce JM (2003) Revolutionising hand hygiene in health-care settings: guidelines revisited. Lancet Infect Dis 3: 269–270
Herwaldt LA, Geiss M, Kao C, Pfaller MA (1996) The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis 22: 14–20
Paradisi F, Corti G, Sbaragli S, Benedetti M (2002) Effect of antibiotic pretreatment on resistance. Semin Respir Infect 17: 240–245
McGowan JE Jr (1983) Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 5: 1033–1048
Fridkin SK (2001) Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 29: N64–68
Fridkin SK (2001) Vancomycin-intermediate and_-resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 32: 108–115
Fridkin SK (2003) Routine cycling of antimicrobial agents as an infection-control measure. Clin Infect Dis 36: 1438–1444
Coast J, Smith RD (2003) Solving the problem of antimicrobial resistance: is a global approach necessary? Drug Discov Today 8: 1–2
Smith RD, Coast J (2002) Antimicrobial resistance: a global response. Bull World Health Organ 80: 126–133
Lipsitch M, Samore MH (2002) Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 8: 347–354
Lipsitch M, Dykes JK, Johnson SE, et al (2000) Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine 18: 2895–2901
Lipsitch M, Bergstrom CT, Levin BR (2000) The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci USA 97: 1938–1943
Shinefield HR, Ribble JC, Boris M, Eichenwald HF, Aly R, Maibach H (1974) Bacterial interference between strains of S. aureus. Ann NY Acad Sci 236: 444–455
Aly R, Maibach HI, Shinefield HR, Mandel A, Strauss WG (1974) Bacterial interference among strains of Staphylococcus aureus in man. J Infect Dis 129: 720–724
Aly R, Maibach HI, Shinefield HR, Mandel AD (1974) Staphylococcus aureus carriage in twins. Am J Dis Child 127: 486–488
Wood MJ, Moellering RC Jr (2003) Microbial resistance: bacteria and more. Clin Infect Dis 36: S2–3
Vincent JL, Jacobs F (2003) Infection in critically ill patients: clinical impact and management. Curr Opin Infect Dis 16: 309–313
Vincent JL (2003) Nosocomial infections in adult intensive-care units. Lancet 361: 2068–2077
Houghton D (2002) Antimicrobial resistance in the intensive care unit: understanding the problem. AACN Clin Issues 13: 410–420
Hsueh PR, Chen ML, Sun CC, et al (2002) Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981–1999 Emerg Infect Dis 8: 63–68
Gastmeier P, Geffers C, Sohr D, Schwab F, Behnke M, Rüden H (2003) Surveillance nosokomialer Infektionen in Intensivstationen: Aktuelle Daten und Interpretationen. Wien Klin Wochenschr 115: 99–103
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Knauer, A., Fladerer, P., Strempfl, C. et al. Effect of hospitalization and antimicrobial therapy on antimicrobial resistance of colonizingStaphylococcus epidermidis . Wien Klin Wochenschr 116, 489–494 (2004). https://doi.org/10.1007/BF03040945
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03040945